Evexia Lifecare: Promoter buys 21.97 lakh shares

What was disclosed and why it matters

Evexia Lifecare Limited saw a fresh round of promoter-group buying in the open market, with disclosures filed under SEBI takeover and insider trading regulations. Shree Saibaba Exim Private Limited, classified as part of the promoter group, reported acquiring 21,97,322 equity shares on September 4, 2026. The buying followed two other disclosed purchases earlier in the same week, indicating a sequence of transactions rather than a one-off trade. Such filings matter because they update the market on changes in ownership and voting rights, especially when the buyer is part of the promoter group. The disclosures referenced Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

September 4, 2026: 21,97,322 shares bought in open market

The September 4 purchase was executed in the open market and increased Shree Saibaba Exim’s holding to 2,59,36,946 shares. After the transaction, the entity’s stake was reported at 1.376% of Evexia Lifecare’s total voting capital. Before this trade, it held 2,37,39,624 shares, equal to 1.259%. The filing also states the incremental change from this specific purchase was 0.117% of the company’s voting capital. The disclosure specifies that no warrants or convertible securities were involved, and voting rights were linked only to equity shares. It also states that there were no encumbrances or pledges on the shares held by the acquirer.

September 3, 2026: additional open-market purchase of 32,80,000 shares

A separate disclosure states that Shree Saibaba Exim acquired 32,80,000 shares on September 3, 2026 through open-market purchases. This purchase was disclosed under Regulation 29(2) of the SEBI (SAST) Regulations, 2011. The provided context also includes a Marathi summary stating that the promoter group entity’s stake increased to 1.259% after buying 32.8 lakh shares, and that promoters’ holding rose from 1.089% to 1.259% due to this transaction. Taken together with the September 4 filing that places the entity at 1.376%, the disclosures indicate continued buying across consecutive sessions. The information provided does not include the purchase price, broker details, or average acquisition cost. It also does not mention any change in the company’s total share capital linked specifically to these transactions.

September 2, 2026: 2,03,95,000 shares acquired; stake jumps from 0.003%

The largest reported purchase in the sequence was on September 2, 2026, when Shree Saibaba Exim acquired 2,03,95,000 equity shares of Evexia Lifecare in the open market. This transaction was disclosed under Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (PIT) Regulations, 2015, and also triggered disclosure under Regulation 29(2) of the SEBI (SAST) Regulations, 2011. Prior to this transaction, the acquirer reportedly held 64,624 shares, representing 0.003% of the total share capital. Following the September 2 purchase, the holding was reported at 2,04,59,624 shares, or 1.089% of the voting capital. The disclosure also states there were no encumbrances, pledges, or convertible securities involved.

Total share capital and ownership context

One disclosure notes that Evexia Lifecare’s total share capital remained unchanged at 187,73,28,995 shares. Another section states the total equity share capital and total voting capital remain at Rs. 187.73 crores (as provided in the source text). Separately, the shareholding pattern referenced in the provided material reports total promoters at 3.36% as of 09-2026. The same snapshot lists Mutual Funds at 0.02%, Foreign Institutional Investors at 0.12%, Domestic Institutional Investors at 0.08%, and Retail at 96.41%. These figures provide background for interpreting why even incremental promoter-group purchases can stand out in a stock with high retail ownership. The disclosures shared here relate to one promoter group entity, not necessarily the entire promoter holding.

Other disclosed buying: Kiran Kumar Jain M. adds 1,00,000 shares

Apart from promoter-group activity, the material also includes a disclosure involving an individual acquirer, Kiran Kumar Jain M., stated to be not part of the promoter or promoter group. According to the text, he acquired 1,00,000 shares via an open-market purchase on June 15, 2026, raising his holding to 11,00,00,000 shares and 5.86% of total voting capital. The filing is described as made in compliance with Regulation 29(2) of the SEBI (SAST) Regulations, 2011. The same set of details notes that prior to this purchase he held 10,99,00,000 shares (5.85%), and that the incremental 1,00,000 shares represented 0.01% of total share capital. It further states there were no warrants, convertible securities, or other instruments involved, and no encumbrances such as pledge or lien were reported. The provided material also contains another summary that mentions 11 crore shares representing 86% voting rights and an acquisition date of 5 June 2025, which differs from the 5.86% figure and June 15, 2026 date presented elsewhere.

Key facts table: promoter-group purchases disclosed in September 2026

Market impact: what these filings change for investors

From a market-structure perspective, these disclosures primarily update investors on voting-rights changes rather than company operations. The September 4 filing quantifies the step-up clearly, taking Shree Saibaba Exim from 1.259% to 1.376% in Evexia Lifecare. The September 2 disclosure shows the most material jump, from a reported 0.003% to 1.089% after acquiring 2,03,95,000 shares. In addition, the filings explicitly state that the purchases involved no warrants, convertible securities, or other instruments, which limits ambiguity about potential future dilution from these transactions. They also state that there were no pledges or encumbrances on the shares held by the acquirer, a datapoint often tracked by investors assessing promoter leverage. The material provided does not include stock price reaction, trading volumes, or valuation impact, so the market effect cannot be quantified from the disclosed data alone.

Analysis: why consecutive open-market buys draw attention

Consecutive open-market purchases by a promoter-group entity typically attract attention because they indicate an increase in aligned ownership, and they are closely monitored under SEBI’s disclosure framework. Here, the significance is amplified by the sharp increase reported on September 2, followed by additional buying on September 3 and September 4. The disclosures also highlight that Evexia Lifecare has a high retail shareholding base (96.41% as per the cited pattern), which can make promoter-group changes more visible on a percentage basis even when the absolute percentage remains low. At the same time, the promoter shareholding figure cited (3.36% as of 09-2026) suggests that promoter holdings are relatively small in aggregate compared with many listed peers, based on the snapshot provided. For readers tracking ownership signals, the clean nature of the trades in the filings, with no convertibles and no encumbrances, is a key factual takeaway. Separately, the presence of differing summaries in the provided material for the non-promoter acquirer’s percentage and dates underscores why investors typically cross-check the exact exchange filing when interpreting such events.

Conclusion

Disclosures for Evexia Lifecare indicate that promoter-group entity Shree Saibaba Exim Private Limited carried out multiple open-market purchases between September 2 and September 4, 2026, culminating in a reported holding of 1.376%. The filings cite SEBI PIT and SEBI SAST regulations and state there were no convertibles and no pledges or encumbrances on the shares held by the acquirer. A separate disclosure in the provided material also notes an open-market purchase by non-promoter Kiran Kumar Jain M. that took his holding to 5.86%, though other summaries in the same material describe different dates and percentages. The next concrete updates for investors would typically come through subsequent exchange disclosures if further purchases occur or if shareholding pattern filings reflect these changes in aggregate.